Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis: Outcomes from a Single Tertiary Institution

Journal of Gastrointestinal Surgery

Volumn 18, Issue 5, 2014, Pages 1024-1031

  Tabrizian, Parissa ^a   Shrager, Brian ^b   Jibara, Ghalib ^c   Yang, Ming Jim ^a   Romanoff, Anya ^a   Hiotis, Spiros ^a   Sarpel, Umut ^a   Labow, Daniel M ^a  

^a MOUNT SINAI MEDICAL CENTER   (United States)

^b MORRISTOWN MEDICAL CENTER   (United States)

^c BROOKDALE UNIVERSITY HOSPITAL AND MEDICAL CENTER   (United States)

Author keywords

Colorectal cancer; Hyperthermic intraperitoneal chemotherapy; Outcome; Peritoneal carcinomatosis

Indexed keywords

ANTINEOPLASTIC AGENT; CAMPTOTHECIN; IRINOTECAN; MITOMYCIN; OXALIPLATIN; PLATINUM COMPLEX;

ADULT; AGED; ANALOGS AND DERIVATIVES; APPENDIX TUMOR; BLOOD TRANSFUSION; CARCINOMA; COLORECTAL TUMOR; CYTOREDUCTIVE SURGERY; FEMALE; GALLBLADDER TUMOR; HUMAN; HYPERTHERMIC THERAPY; MALE; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; OVARY TUMOR; PATHOLOGY; PERITONEAL NEOPLASMS; PEROPERATIVE CARE; PSEUDOMYXOMA PERITONEI; SECONDARY; STOMACH TUMOR; SURVIVAL RATE; TERTIARY CARE CENTER; TUMOR RECURRENCE;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; APPENDICEAL NEOPLASMS; BLOOD TRANSFUSION; CAMPTOTHECIN; CARCINOMA; COLORECTAL NEOPLASMS; COMBINED MODALITY THERAPY; CYTOREDUCTION SURGICAL PROCEDURES; FEMALE; GALLBLADDER NEOPLASMS; HUMANS; HYPERTHERMIA, INDUCED; INTRAOPERATIVE CARE; MALE; MIDDLE AGED; MITOMYCIN; NEOPLASM RECURRENCE, LOCAL; ORGANOPLATINUM COMPOUNDS; OVARIAN NEOPLASMS; PERITONEAL NEOPLASMS; PSEUDOMYXOMA PERITONEI; STOMACH NEOPLASMS; SURVIVAL RATE; TERTIARY CARE CENTERS;

EID: 84900334842     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11605-014-2477-5     Document Type: Article

References (29)

1. Glehen O, Mohamed F, Gilly FN. Peritoneal carcinomatosis from digestive tract cancer: new management by cytoreductive surgery and intraperitoneal chemohyperthermia. Lancet Oncol 2004; 5: 219e28.
2. Chua TC, Yan TD, Saxena A, et al. Should the treatment of peritoneal carcinomatosis by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy still be regarded as a highly morbid procedure? A systematic review of morbidity and mortality. Ann Surg. 2009;249: 900-907.
3. Beaujard AC, Glehen O, Caillot JL, et al. Intraperitoneal chemohyperthermia with mitomycin C for digestive tract cancer patients with peritoneal carcinomatosis. Cancer 2000; 88: 2512e9.
4. Verwaal VJ, Bruin S, Boot H, et al. 8 years follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer. Ann Surg Oncol 2008; 15: 2426e32.
5. Roviello F, Marrelli D, Neri A, Cerretani D, de Manzoni G, Pedrazzani C, et al. Treatment of peritoneal carcinomatosis by cytoreductive surgery and intraperitoneal hyperthermic chemoperfusion (IHCP): postoperative outcome and risk factors for morbidity. World J Surg 2006; 30: 2033e40.
6. Glehen O, Osinsky D, Cotte E, et al. Intraperitoneal chemohyperthermia using a closed abdominal procedure and cytoreductive surgery for the treatment of peritoneal carcinomatosis: morbidity and mortality analysis of 216 consecutive procedures. Ann Surg Oncol. 2003;10: 863-869.
7. Elias D, Gilly F, Boutitie F, et al. Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a multicentric French study. J Clin Oncol 2010; 28: 63e8.
8. Elias D, Goere D, Blot F, et al. Optimization of hyperthermic intraperitoneal chemotherapy with oxaliplatin plus irinotecan at 43 degrees C after compete cytoreductive surgery: mortality and morbidity in 106 consecutive patients. Ann Surg Oncol. 2007;14: 1818-1824.
9. Levine EA, Stewart JH, Russell GB, et al. Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy for peritoneal surface malignancy: experience with 501 procedures. J Am Coll Surg. 2007;204: 943-953.
10. Chua TC, Saxena A, Schellekens JF, et al. Morbidity and mortality outcomes of cytoreductive surgery and perioperative intraperitoneal chemotherapy at a single tertiary institution: towards a new perspective of this treatment. Ann Surg. 2010;251: 101-106.
11. Clavien PA, Barkun J, de Oliveira ML et al. The Clavien-Dindo classification of surgical complications: five-year experience Ann Surg. 2009 Aug; 250(2): 187-96.
12. Jacquet P, Sugarbaker PH. Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. Cancer Treat Res 1996; 82: 359e74.
13. Jacquet P, Sugarbaker PH. Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. In: Sugarbaker PH, editor. Peritoneal carcinomatosis: principles of management. Boston, USA: Kluwer Academic Publishers; 1996. p. 359e74.
14. Roviello F, Caruso S., Marrelli D. et. al Treatment of peritoneal carcinomatosis with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: State of the art and future developments. Surg Oncol. 2011; 20(1): e38-54.
15. Sugarbaker PH, Alderman R, Edwards G, et al. Prospective morbidity and mortality assessment of cytoreductive surgery plus perioperative intraperitoneal chemotherapy to treat peritoneal dissemination of appendiceal mucinous malignancy. Ann Surg Oncol. 2006;13: 635-644.
16. Glehen O, Kwiatkowski F, Sugarbaker PH, et al. Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study. J Clin Oncol 2004; 22: 3284e92.
17. Sugarbaker PH, Chang D. Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy. Ann Surg Oncol 1999; 6: 727e31.
18. Gusani NJ, Cho SW, Colovos C, et al. Aggressive surgical management of peritoneal carcinomatosis with low mortality in a high-volume tertiary cancer center. Ann Surg Oncol 2008; 15: 754e63.
19. Saxena A, Yan TD, Chua TC, Morris DL. Critical assessment of risk factors for complications after cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei. Ann Surg Oncol; 2009.
20. Baratti D, Kusamura S, Mingrone E et al. Identification of a subgroup of patients at highest risk for complications after surgical cytoreduction and hyperthermic intraperitoneal chemotherapy Ann Surg. 2012; 256(2): 334-41.
21. Cameron JL, Riall TS, Coleman J et al. One thousand consecutive pancreaticoduodenectomies Ann Surg. 2006; 244(1): 10-5.
22. Jarnagin WR, Gonen M, Fong Y, et al. Improvement in perioperative outcome after hepatic resection: analysis of 1, 803 consecutive cases over the past decade. Ann Surg 2002; 236.
23. Katz SC, Shia J, Liau KH, et al. Operative blood loss independently predicts recurrence and survival after resection of hepatocellular carcinoma. Ann Surg 2009; 249: 617-23.
24. Mörner ME, Gunnarsson U, Jestin P, et al. The importance of blood loss during colon cancer surgery for long-term survival: an epidemiological study based on a population based register. Ann Surg. 2012; 255(6): 1126-8.
25. Franko J, Gusani NJ, Holtzman MP, et al. Multivisceral resection does not affect morbidity and survival after cytoreductive surgery and chemoperfusion for carcinomatosis from colorectal cancer. Ann Surg Oncol. 2008;15: 3065-3072.
26. Esquivel J, Chua TC, Stojadinovic A, et al. Accuracy and clinical relevance of computed tomography scan interpretation of peritoneal cancer index in colorectal cancer peritoneal carcinomatosis: a multi-institutional study. J Surg Oncol. 2010; 102: 565-570.
27. Chua TC, Al-Zahrani A, Saxena A, et al. Determining the association between preoperative computed tomography findings and postoperative outcomes after cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei. Ann Surg Oncol. 2011; 18: 1582-1589.
28. Iversen LH, Rasmussen PC, Laurberg S. Value of laparoscopy before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis. Br J Surg. 2013; 100(2): 285-92.
29. Smeenk RM, Verwaal VJ, Zoetmulder FAN. Learning curve of combined modality treatment in peritoneal surface disease. Br J Surg. 2007;94: 1408-1414.